Getting new contracts is a definite positive, but earnings from these contracts is what matters. Everyone expecting explosive growth in the stock price got sucked in yesterday. I expect RGDX will bounce around in the 1.20 - 1.40 range until the company announces positive earnings growth. I am not sure about their financial position, but bio-techs often try to raise $ after reporting positive news. If RGDX needs $ and dilutes, I expect the stock will go back to where it was before the positive news. IMHO.